AMERICAN FINANCIAL GROUP INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMERICAN FINANCIAL GROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.17B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $8.32B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $7.83B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $7.04B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $6.55B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $2.62B | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $2.06B | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $1.95B | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $1.28B | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $2.13B | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $842.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $887.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $852.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $898.00M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.00B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $692.00M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $164.00M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $177.00M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | ($301.00M) | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $211.00M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.07B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.12B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.07B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.12B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.34B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $339.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $634.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $639.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $724.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $787.00M | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.06B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.01B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.94B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.72B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.55B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.63B | Feb 24, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.53B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.15B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.97B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.15B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.71B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.18B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $2.46B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $2.08B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.80B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $1.15B | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.64B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $30.84B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $29.79B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $28.83B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $28.93B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $73.71B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $70.13B | Feb 25, 2021 |
| FY2020 | Dec 31, 2018 | $63.46B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $60.66B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $55.07B | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.82B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $26.37B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $25.53B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $24.78B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $23.92B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $66.92B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $63.86B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $58.48B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $55.32B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $50.15B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.82B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.47B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $4.26B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $4.05B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $5.01B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $6.79B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $6.27B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $4.97B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $5.33B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $4.92B | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $327.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $305.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $305.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $246.00M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $246.00M | Feb 23, 2024 |
| FY2023 | Dec 31, 2020 | $176.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $176.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $176.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $199.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $199.00M | Feb 25, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.73B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.41B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.23B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $872.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.13B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.67B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $2.31B | Feb 25, 2021 |
| FY2020 | Dec 31, 2018 | $1.52B | Feb 25, 2021 |
| FY2020 | Dec 31, 2017 | $2.34B | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $2.11B | Feb 25, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.82B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.48B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.50B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.96B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.96B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.47B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.30B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.30B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1.28B | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 10 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 10 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 10 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 23 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 7 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | (3) | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 10 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 10 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 10 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 23 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 7 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | (3) | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 83.42M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 83.98M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 83.64M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 85.20M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 84.92M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 86.35M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 90.30M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 89.29M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 88.28M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 86.92M | Feb 23, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $606.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $788.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $684.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.21B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.37B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $334.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $444.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $394.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $417.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $185.00M | Feb 26, 2019 |